Next Article in Journal
Local and Systemic Effects of Porphyromonas gingivalis Infection
Previous Article in Journal
Fungus under a Changing Climate: Modeling the Current and Future Global Distribution of Fusarium oxysporum Using Geographical Information System Data
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Microorganisms
Volume 11
Issue 2
10.3390/microorganisms11020469
microorganisms-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Novel Strain of Probiotic Leuconostoc citreum Inhibits Infection-Causing Bacterial Pathogens

by
Karnan Muthusamy
1,†,
Hyo-Shim Han
2,†,
Ilavenil Soundharrajan
1,
Jeong-Sung Jung
1,
Mariadhas Valan Arasu
3 and
Ki-Choon Choi
1,*
1
Grassland and Forages Division, National Institute of Animal Science, Rural Development Administration, Cheonan 31000, Republic of Korea
2
Department of Biotechnology, Sunchon University, Suncheon 540742, Republic of Korea
3
Department of Botany and Microbiology, College of Science, King Saud University, P.O. Box 2455, Riyadh 11451, Saudi Arabia
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Microorganisms 2023, 11(2), 469; https://doi.org/10.3390/microorganisms11020469
Submission received: 13 January 2023 / Revised: 8 February 2023 / Accepted: 11 February 2023 / Published: 13 February 2023
(This article belongs to the Section Antimicrobial Agents and Resistance)
Browse Figures
Review Reports Versions Notes

Abstract

:
Infectious diseases caused by bacteria are at risk of spreading and prolonging due to antimicrobial resistance. It is, therefore, urgently necessary to develop a more effective antibiotic alternative strategy to control pathogen spread. In general, probiotics have been recommended as a substitute for antibiotics that inhibit pathogens. This study was isolated and probiotic characteristics and antibacterial bacterial efficiency against various infection-causing pathogens were determined by different in vitro methods. A 16S rRNA sequence confirmed that the isolated strains belonged to a species of Leuconostoc citreum. L. citreum KCC-57 and KCC-58 produced various extracellular enzymes and fermented different carbohydrates. There was significant tolerance for both strains under the harsh conditions of the gastrointestinal tract (GIT). In addition, L. citreum KCC-57 and L. citreum KCC-58 showed significant auto-aggregations and hydrophobicity properties that varied with incubation time. Moreover, the cell-free secondary supernatant (CFS) of L. citreum KCC-57 and L. citreum KCC-58 inhibited growth of Enterococcus faecalis, Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus. According to a co-culture study, L. citreum KCC-57 and L. citreum KCC-58 were highly competitive for pathogen growth. L. citreum KCC-57 and L. citreum KCC-58 showed significant probiotic potential and strong antibacterial activities against different pathogens, suggesting that these strains could be used instead of antibiotics to control infectious pathogens.

1. Introduction

The global population rate and microbial pathogen-associated infections have been increasing continuously for decades. Millions of lives are lost every year due to microbial infections. Antimicrobial resistance (AMR) is the primary cause of microbial infections. It is one of the biggest threats to human health in the 21st century because pathogens are becoming less susceptible to drug treatments. AMR is predicted to kill ten million people by 2050 [1,2]. According to the World Health Organization (WHO) and other researchers, AMR is an emergency issue that requires key strategies to control it globally [3,4,5]. There were 4.9 million deaths in 2019 from bacterial infections, of which 1.27 million were caused by antimicrobial resistance. At all ages, Western sub-Saharan Africa had the highest death rates due to AMR. Among the pathogens, E. coli, A. baumannii, K. pneumoniae, P. aeruginosa and S. aureus are associated with antimicrobial resistance. In total, 929,000 deaths were caused by these pathogens in 2019 and 3.57 million in 2020. Over 100,000 deaths have been associated with methicillin-resistant S. aureus in 2019 [6].
In order to control AMR pathogens, effective antibiotics must be invented. Recently, antibiotics have become less effective due to microbial resistance. Therefore, treatment has become more challenging. There is a need for emerging and alternative strategies to protect valuable life from AMR pathogens. According to recent research, probiotics are the most effective tool for controlling AMR pathogens. Probiotic bacteria such as Lactobacillus and Bifidobacterium have a variety of biological applications [7]. Lactic acid bacteria (LAB) produce a variety of secondary metabolites that are potential antimicrobials, antioxidants and other biological agents [8,9,10]. The secondary metabolites of LAB inhibit pathogen growth via multiple molecular mechanisms [11,12,13,14,15]. LAB can also prevent the attachment of pathogenic microbes to the epithelial cells by competing with pathogens and reducing colonization of pathogens, thereby reducing infection [16,17,18]. Therefore, we intended to use Leuconostoc citreum from rice plants to control various pathogens in this regard. L. citreum is a dextran-producing species and is believed to have significant probiotic potential due to its putative plasmid-encoded cell wall anchored protein, which contains five mucus-binding domains essential for colonizing the digestive system. As well as producing various antimicrobial peptides [19,20,21], it is also capable of killing cancer cells [22]. Hence, in the present study, potential L. citreum was isolated and analyzed for its biological potential, including survival ability in acidic and bile salt environments, antibacterial activity against infection-causing bacterial pathogens by different in vitro methods including time- and dose-based killing assay, minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC), as well as competitive growth between LAB and bacterial pathogens.

2. Methods and Materials

2.1. Lactic Acid Bacteria Isolation (LAB) and Characterization

The whole rice plant was collected from an agriculture field in Division of Grassland and Forage, Cheonan, South Korea. The LAB were isolated using De Man Rogosa and Sharpe agar (MRS) and the identity was confirmed by bromocresol purple agar medium (BCP) [23,24]. APICH50 and AbiZym detection kits (MarcyI Etoile, France) were used to measure carbohydrate fermentation and extracellular enzyme production by selected strains, respectively. The 16S rRNA sequences of isolate were performed by Solgent Pvt Ltd. (Daejeon, Republic of Korea) and identified at the species by NCBI blast tool and the sequences were deposited to NCBI GeneBank (GeneBank: OL677067-OL677068).

2.2. Probiotic Potential of Selected LAB

Active fresh cultures (24 h) of isolated strains were tested in simulated gastrointestinal juices (gastric, duodenal and intestinal) [23,25]. A hydrophobicity assay was conducted [26] and the aggregation properties [27] of selected isolates were determined.

2.3. Antibacterial Activity Well Diffusion

Isolates were grown in MRS broth for 48 h at 37 °C in a 1000 mL glass bottle with butyl stoppers. Cell free supernatant (CFS) was collected by centrifuge for 30 min at 4000× g, 4 °C and used to determine antibacterial activity. S. aureus, E. faecalis, E. coli and P. aeruginosa were obtained from KACC, Korea (Korean Agriculture Culture Collection) and cultured in nutrient broth (NB) for 24 h at 37 °C. Each pathogen at the density of 108 CFU/mL was spread onto nutrient agar (NA) plates and made a well on it. The CFS (100 μL/well) was dispensed into the well which was made on NA and incubated at 37 °C for 48 h. The inhibitory activity was monitored.

2.4. Lyophilization of Cell-Free Supernatant (CFS)

The isolates were grown in MRS broth at 37 °C for 48 h with mild shaking in an arbitrary shaker. The CFS was separated at 4000× g, 4 °C for 30 min and then the pH of the CFS was adjusted with 1N NaOH and filtered by different filter papers with different pour size. CFS was then lyophilized under pressure (less than 50 m Torr) using an Ilshin Biobase (Gyeonggi-do, Republic of Korea).

2.5. Antibacterial Activity by Dose- and Time-Based Killing Assay, Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC)

The CFS was suspended in NB at the final concentration of 25 mg/mL. Then, the samples were serially diluted (twofold) with same broth from 25 mg/mL to 0.02 mg/mL. The diluted samples were then (100 μL/mL) transferred to microplate wells with triplicates and ten microliters of each pathogen was inoculated into each well. Blank wells with CFS from each concentration were also maintained. The experimental plates were incubated for 48 h at 37 °C. The samples from each well were taken at different incubatory intervals (12, 24, 36 and 48 h) and intensity of samples was measured at 600 nm. The absorbance values were then normalized with blanks [28]. The MIC and MBC were also identified [23,29].

2.6. Antibacterial Activity by Co-Culture Method

The competitive growth between pathogen and LAB was identified by co-culture method [30,31] with minor modifications. MRS and nutrient broth were used to cultivate LAB and pathogen, respectively. The bacterial cultures were grown at 37 °C for 24 h. The pellets were then collected by centrifugation at 4000× g, 4 °C for 30 min. Then, bacterial pellets were washed with PBS twice, and suspended in PBS. For co-culturing LAB with pathogen, MRS and nutrient broth was used at a 1:1 ratio. The control (monoculture) was grown at 37 °C with individual inoculations of LAB and pathogen. Sampling was performed at 12, 24 and 36 h. On MRS and NA agar plates, colonies were counted and compared with monocultures.

2.7. Statistical Analysis

Data obtained from the experiments were analyzed by SPSS16 version statistical software (SPSS Inc., Chicago, IL, USA). The experimental data were represented as the Mean ± STD. Statistics were considered significant when p values were less than 0.05.

3. Results

3.1. LAB Strain Isolation and Characterization

The selected isolates were characterized based on their primary antimicrobial activities and their ability to survive under gastrointestinal tract (GIT) conditions. These strains were Gram-positive, coccus shape, negative catalase and non-motile type (Table 1). These strains were identified as Leuconostoc citreum based on 16S rRNA sequence data. A number of carbohydrate substrates were fermented by both L. citreum KCC-57 and L. citreum KCC-58 including glucose, fructose, mannose, maltose, lactose, N-acetylglucosamine and gentiobiose, etc. (Supplementary Table S1). The strains also produce different types of extracellular enzymes such as alkaline phosphatases, acid phosphatases, Naphthol-AS-biphosphohydrolase, β-Glucosidase and α-Glucosidase (Supplementary Table S2).

3.2. Potential Probiotic Properties of Isolated Strains

3.2.1. LAB in Simulated GIT Conditions

The strains should be able to survive in acidic and bile salt environments in order to be considered probiotics. Consequently, the survival capability of L. citreum KCC-57 and L. citreum KCC-58 in gastric juice with a pH of 2.5, duodenal juice with a pH of 5 and intestinal juice with a pH of 8 were evaluated. L. citreum KCC-57 and L. citreum KCC-58 survived in gastric juice at rates of 30.25% and 34.37%, respectively. Duodenal juice (L. citreum KCC-57: 41.98% vs. L. citreum KCC-58: 62.21%) and intestinal juice (L. citreum KCC-57: 87.55 vs. L. citreum KCC-58: 83.28%) survival rates were higher than gastric juice (Figure 1A).

3.2.2. Hydrophobicity and Auto-Aggregation

Selection of probiotic strains is dependent on their hydrophobicity and aggregation properties, which determine their adherence and colonization ability. The hydrophobicity properties of L. citreum KCC-57 and L. citreum KCC-58 varied with time in chloroform and xylene. Hydrophobicity properties of L. citreum KCC-57 were 21.97–63.37% in chloroform and 31.51–43.50% in xylene at various incubation times (30 min–180 min). L. citreum KCC-58 accounted for 29.36 to 71.60% in chloroform and 31.72–54.20% in xylene. All strains showed a much higher degree of hydrophobicity in chloroform than in xylene at 180 min (Figure 1B). A time-dependent auto-aggregation study showed that both strains had broad range of aggregation abilities. L. citreum KCC-57 showed gradual sedimentation increases in the bottom of tubes and claimed to reduce turbidity at the same time, whereas L. citreum KCC-58 showed lower sedimentation rates and higher turbidities. After 180 min of incubation, both strains displayed higher percentages of aggregation properties (Figure 1C).

3.3. The Antibacterial Activities of Selected Isolates L. citreum KCC-57 and L. citreum KCC-58

3.3.1. Agar Well Diffusion

L. citreum KCC-57 and L. citreum KCC-58 strains showed significant probiotic characteristics, and then we analyzed for their antibacterial activity against S. aureus, P. aeruginosa, E. coli and E. faecalis. L. citreum KCC-57 and L. citreum KCC-58 CFS showed a wide range of zones of inhibition against tested pathogens (Table 2). The CFS of L. citreum KCC-57 and KCC-58 showed strong inhibitory zones against E. coli, followed by S. aureus, E. Faecalis and P. aeruginosa.

3.3.2. Time-Killing Assay

The effects of L. citreum KCC-57 (Figure 2) and L. citreum KCC-58 (Figure 3) at different concentrations were investigated after different incubation periods. Depending on the concentration of CFS used (0.02–25 mg/mL), different antibacterial activities were observed against pathogens between 12 and 48 h. Time-based treatment reduced pathogen growth compared with untreated pathogens. All pathogens were highly susceptible to CFS of both strains at 25 mg/mL. The pathogen’s growth was increased when the concentration of CFS was reduced with an extended period.

3.3.3. MIC and MBC

There was a difference between L. citreum KCC-57 and L. citreum KCC-58 treatments in terms of MIC and MBC. KCC-57 had MIC values of 12.5 mg/mL for E. coli, E. faecalis P. aeruginosa and 25 mg/mL for S. aureus. A KCC-58 MIC value was between 6.25 mg/mL and 12.5 mg/mL for all tested pathogens, including E. faecalis P. aeruginosa, S. aureus and E. coli. Strong bactericidal activity (MBC) was noted against E. coli and P. aeruginosa at 25 mg/mL. No MBC values were observed for E. faecalis and S. aureus. KCC-58, at doses between 12.5 mg/mL and 25 mg/mL, showed strong bactericidal activity (MBC) against all tested pathogens (Table 3).

3.3.4. Co-Culture of LAB with Pathogens

It was found that L. citreum KCC-57 and L. citreum KCC-58 have significant probiotic potential, as well as strong antibacterial activity. In modified broth (MRS-NB, 1:1), the LAB were grown competitively with pathogens. A co-culture between pathogens and LAB was shown to exert a strong inhibitory effect against pathogen growth via dominating LAB growth, as confirmed by growth of pathogens and LAB on nutrient agar and MRS agar, respectively. The ability of L. citreum KCC-57 and L. citreum KCC-58 to reduce pathogen growth could facilitate prevention of pathogen growth by increasing colonization and biofilm formation in the GIT (Table 4).

4. Discussion

Infectious bacteria are associated with a number of chronic and acute diseases, among them E. faecalis S. aureus, P. aeruginosa and E. coli, causing diarrhea [32], intestinal inflammation [33], colon cancer, oral cancer lesions [34] and urinary tract infections [35,36]. Antibiotics have made a significant contribution to medical science by being able to prevent pathogens from spreading, thereby decreasing death rates. Occasionally, antibiotics are not effective at controlling the spread of pathogens due to the emergence of antibiotic-resistant bacteria [3]. Therefore, effective strategies are needed to prevent and control such diseases. Researchers consider LAB to be the most potential probiotics because they possess a broad range of antimicrobial properties [37,38]. In the current study, two novel L. citreum KCC-57 and L. citreum KCC-58 were selected and characterized for their biological potential, including carbohydrate fermentation, enzyme production and survival in GIT juices, as well as antibacterial activities against E. coli, E. faecalis, P. aeruginosa and S. aureus. A variety of carbohydrate substrates could be fermented, and different enzymes were produced by both strains. The strains should have resistance to low pH and bile salt environments [39,40] in order to be considered probiotics. In this study, we found that both L. citreum KCC-57 and L. citreum KCC-58 survived significantly in simulated gastric juice (pH 2.5) without nutrients. Despite the fact that both strains showed a lower survival rate under this harsh condition, more than 30% of the strains were able to survive. Previous studies have been suggested that Leuconostoc spp. TBE-8 and P1 lose survival rates at lower pH (pH 3 and pH 4 in MRS broth), but a significant number of colonies can tolerate acidic pH in the presence of MRS containing nutrients. However, our strains L. citreum KCC-57 and L. citreum KCC-58 survived significantly in lower pH (pH 2.5) without nutrition (acidic pH in PBS) compared to previously reported Leuconostoc spp. [41,42]. Furthermore, the resistant capacity of L. citreum KCC-57 and L. citreum KCC-58 was found to be higher in duodenal and intestinal juices compared to gastric juice. It suggests that both L. citreum KCC-57 and L. citreum KCC-58 acquired significant stress tolerance and resistant capacities from gastric juice. Bile salt concentrations in the GIT range from 0.3 to 0.5% [43]. Probiotics with bile salt resistance are associated with the bile salt hydrolase enzyme, which hydrolyzes conjugated bile salts [44]. In the current study, it was confirmed that both strains were capable of surviving in a bile salt environment. In general, bile salts have detrimental effects that limit microbial growth. Overall, these strains gained tolerance in their stomach juice and improved their ability in subsequent unfavorable conditions, referred to as the cross-protective stress response [45], before reaching the intestinal wall and re-establishing the gut microbiome and inhibiting undesirable microbial growth [23]. Leuconostoc sp. showed better tolerance when bile salt concentrations were less than 0.4% [41]. An adhesion assay is used to assess bacteria’s ability to adhere to epithelia in the gastrointestinal tract [46,47]. Furthermore, auto-aggregation contributes to biofilm development that increases intestinal colonization and prevents pathogen adhesion. In the present study, L. citreum KCC-57 and L. citreum KCC-58 showed significant hydrophobicity characteristics in chloroform and xylene. Both strains expressed higher hydrophobicity properties in chloroform than in xylene. Additionally, these strains exhibited considerable levels of auto-aggregation in a time-dependent manner, confirming that selected isolates could be able to interact with mucous or epithelial cells which help to inhibit adhesion of pathogens [48]. LAB have antimicrobial activity directly associated with production of organic acids such as lactic acid, acetic acid, propionic acid, hydrogen peroxide, bacteriocins and peptides [49,50]. L. citreum KCC-57 and L. citreum KCC-58 have been shown to have strong antibacterial activity against E. coli, P. aeruginosa, S. aeruginosa and E. faecalis as determined by agar well diffusion, microdilution, MIC/MBC, time- and dose-dependent killing assay and dual culture methods. Several studies indicated that the Lactobacillus sp. and Leuconostoc sp. possessed strong antimicrobial activity via the production of secondary metabolites, nutrient utilization competition, inhibition of adhesion of bacterial to the intestinal mucosa and an improved immunological response [37,38,51]. CFS of L. citreum KCC-57 and L. citreum KCC-58 demonstrated broad antibacterial activity against all tested pathogens. Inhibitory activities have varied between strains L. citreum KCC-57 and L. citreum KCC-58. An MIC/MBC and time-/dose-dependent study also supported the antibacterial activity of L. citreum KCC-57 and L. citreum KCC-58. The maximum concentration of CFS used in this study (25 mg/mL) completely eradicated the growth of pathogens even after 48 h incubation. Finally, the competitive growth study between LAB and pathogens demonstrated that the LAB predominantly dominate the pathogen growth in the customized media. All the methods of antibacterial study suggested that L. citreum KCC-57 and L. citreum KCC-58 possessed strong antagonistic activity against infection-causing pathogens.

5. Conclusions

L. citreum KCC-57 and L. citreum KCC-58 were isolated from rice plants and investigated for their probiotic potential and antibacterial activity. These strains displayed significant survival rates under harsh simulated gastrointestinal conditions and showed good hydrophobicity as well as auto-aggregation properties, which makes them potential probiotic candidates. Additionally, both L. citreum KCC-57 and L. citreum KCC-58 exhibited strong antagonistic activity at different ranges. Co-culture analysis revealed that KCC-57 and KCC-58 inhibit pathogen growth through competitive inhibition, suggesting that they can be used as bio-therapeutic antibacterial agents instead of antibiotics. One of the advantages of the reported strains is its strong antagonistic activity against E. coli, P. aeruginosa, S. aeruginosa and E. faecalis. The disadvantage of the strains is reduced survival rates at pH 2.5. Therefore, these strains must be subjected to gastrointestinal tract conditions in order to determine the true survival rates and other biological potential in in vivo animal models.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/microorganisms11020469/s1, Table S1: In vitro carbohydrate fermentation capability of KCC-57 and KCC-58. Table S2: Extracellular enzyme secretion by KCC-57 and KCC-58.

Author Contributions

Conceptualization, H.-S.H. and K.-C.C.; methodology, I.S. and K.M.; formal analysis, K.M. and J.-S.J.; data curation, H.-S.H., I.S. and M.V.A.; writing—original draft preparation, I.S.; writing—review and editing, M.V.A., H.-S.H. and J.-S.J.; supervision, K.-C.C.; project administration, K.-C.C.; funding acquisition, K.-C.C. All authors have read and agreed to the published version of the manuscript.

Funding

A Cooperative Research Program for Agriculture Science and Technology Development supported this work (Project Name: Technique development for manufacturing high-quality legume silage; Project No. PJ01358902), RDA-NIAS, Republic of Korea.

Data Availability Statement

Please contact the corresponding author if you would like to access the experimental data.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. O’Neill, J. Tackling Drug-Resistant Infections Globally: Final Report and Recommendations; Government of the United Kingdom: London, UK, 2016. [Google Scholar]
  2. O’Neill, J. Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations; Wellcome Collection: London, UK, 2014. [Google Scholar]
  3. WHO. Antimicrobial Resistance; WHO: Geneva, Switzerland, 2020. [Google Scholar]
  4. CDC. Antibiotic Resistance Threats in the United States; US Department of Health and Human Services: Atlanta, GA, USA, 2019. [Google Scholar]
  5. Prestinaci, F.; Pezzotti, P.; Pantosti, A. Antimicrobial resistance: A global multifaceted phenomenon. Pathog. Glob. Health 2015, 109, 309–318. [Google Scholar] [CrossRef] [PubMed]
  6. Murray, C.J.L.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Robles Aguilar, G. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [Google Scholar] [CrossRef] [PubMed]
  7. Janiszewska-Turak, E.; Hornowska, Ł.; Pobiega, K.; Gniewosz, M.; Witrowa-Rajchert, D. The influence of Lactobacillus bacteria type and kind of carrier on the properties of spray-dried microencapsules of fermented beetroot powders. Int. J. Food Sci. Technol. 2021, 56, 2166–2174. [Google Scholar] [CrossRef]
  8. Aponte, M.; Murru, N.; Shoukat, M. Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective. Front. Microbiol. 2020, 11, 562048. [Google Scholar] [CrossRef] [PubMed]
  9. Muthusamy, K.; Soundharrajan, I.; Srisesharam, S.; Kim, D.; Kuppusamy, P.; Lee, K.D.; Choi, K.C. Probiotic Characteristics and Antifungal Activity of Lactobacillus plantarum and Its Impact on Fermentation of Italian Ryegrass at Low Moisture. Appl. Sci. 2020, 10, 417. [Google Scholar] [CrossRef]
  10. Soundharrajan, I.; Kuppusamy, P.; Srisesharam, S.; Lee, J.C.; Sivanesan, R.; Kim, D.; Choi, K.C. Positive metabolic effects of selected probiotic bacteria on diet-induced obesity in mice are associated with improvement of dysbiotic gut microbiota. FASEB J. 2020, 34, 12289–12307. [Google Scholar] [CrossRef]
  11. Byakika, S.; Mukisa, I.M.; Mugabi, R.; Muyanja, C. Antimicrobial Activity of Lactic Acid Bacteria Starters against Acid Tolerant, Antibiotic Resistant, and Potentially Virulent E. coli. Isolated from a Fermented Sorghum-Millet Beverage. Int. J. Microbiol. 2019, 2019, 2013539. [Google Scholar] [CrossRef]
  12. Kang, C.-H.; Han, S.H.; Kim, Y.; Paek, N.-S.; So, J.-S. In Vitro Probiotic Properties of Lactobacillus salivarius MG242 Isolated from Human Vagina. Probiotics Antimicrob. Proteins 2018, 10, 343–349. [Google Scholar] [CrossRef]
  13. Kim, D.; Min, Y.; Yang, J.; Heo, Y.; Kim, M.; Hur, C.-G.; Lee, S.-C.; Lee, H.-K.; Song, K.-D.; Heo, J.; et al. Multi-Probiotic Lactobacillus Supplementation Improves Liver Function and Reduces Cholesterol Levels in Jeju Native Pigs. Animals 2021, 11, 2309. [Google Scholar] [CrossRef] [PubMed]
  14. Zhang, X.; Ali Esmail, G.; Fahad Alzeer, A.; Valan Arasu, M.; Vijayaraghavan, P.; Choon Choi, K.; Abdullah Al-Dhabi, N. Probiotic characteristics of Lactobacillus strains isolated from cheese and their antibacterial properties against gastrointestinal tract pathogens. Saudi J. Biol. Sci. 2020, 27, 3505–3513. [Google Scholar] [CrossRef]
  15. Vieco-Saiz, N.; Belguesmia, Y.; Raspoet, R.; Auclair, E.; Gancel, F.; Kempf, I.; Drider, D. Benefits and Inputs From Lactic Acid Bacteria and Their Bacteriocins as Alternatives to Antibiotic Growth Promoters During Food-Animal Production. Front. Microbiol. 2019, 10, 57. [Google Scholar] [CrossRef] [PubMed]
  16. Garriga, M.; Rubio, R.; Aymerich, T.; Ruas-Madiedo, P. Potentially probiotic and bioprotective lactic acid bacteria starter cultures antagonise the Listeria monocytogenes adhesion to HT29 colonocyte-like cells. Benef. Microbes 2015, 6, 337–343. [Google Scholar] [CrossRef]
  17. Zawistowska-Rojek, A.; Kośmider, A.; Stępień, K.; Tyski, S. Adhesion and aggregation properties of Lactobacillaceae strains as protection ways against enteropathogenic bacteria. Arch. Microbiol. 2022, 204, 285. [Google Scholar] [CrossRef]
  18. Guan, C.; Chen, X.; Jiang, X.; Zhao, R.; Yuan, Y.; Chen, D.; Zhang, C.; Lu, M.; Lu, Z.; Gu, R. In vitro studies of adhesion properties of six lactic acid bacteria isolated from the longevous population of China. RSC Adv. 2020, 10, 24234–24240. [Google Scholar] [CrossRef]
  19. Iosca, G.; De Vero, L.; Di Rocco, G.; Perrone, G.; Gullo, M.; Pulvirenti, A. Anti-Spoilage Activity and Exopolysaccharides Production by Selected Lactic Acid Bacteria. Foods 2022, 11, 1914. [Google Scholar] [CrossRef] [PubMed]
  20. Pujato, S.A.; del L Quiberoni, A.; Candioti, M.C.; Reinheimer, J.A.; Guglielmotti, D.M. Leuconostoc citreum MB1 as biocontrol agent of Listeria monocytogenes in milk. J. Dairy Res. 2014, 81, 137–145. [Google Scholar] [CrossRef]
  21. Woo, C.; Jung, S.; Fugaban, J.I.I.; Bucheli, J.E.V.; Holzapfel, W.H.; Todorov, S.D. Bacteriocin production by Leuconostoc citreum ST110LD isolated from organic farm soil, a promising biopreservative. J. Appl. Microbiol. 2021, 131, 1226–1239. [Google Scholar] [CrossRef]
  22. Holland, R.; Liu, S.Q. Lactic Acid Bacteria In Leuconostoc spp. In Encyclopedia of Dairy Sciences, 2nd ed.; Fuquay, J.W., Ed.; Academic Press: San Diego, CA, USA, 2011; pp. 138–142. [Google Scholar]
  23. Soundharrajan, I.; Yoon, Y.H.; Muthusamy, K.; Jung, J.-S.; Lee, H.J.; Han, O.-K.; Choi, K.C. Isolation of Lactococcus lactis from Whole Crop Rice and Determining Its Probiotic and Antimicrobial Properties towards Gastrointestinal Associated Bacteria. Microorganisms 2021, 9, 2513. [Google Scholar] [CrossRef] [PubMed]
  24. Valan Arasu, M.; Jung, M.-W.; Ilavenil, S.; Jane, M.; Kim, D.-H.; Lee, K.-D.; Park, H.-S.; Hur, T.-Y.; Choi, G.-J.; Lim, Y.-C.; et al. Isolation and characterization of antifungal compound from Lactobacillus plantarum KCC-10 from forage silage with potential beneficial properties. J. Appl. Microbiol. 2013, 115, 1172–1185. [Google Scholar] [CrossRef]
  25. Casarotti, S.N.; Penna, A.L.B. Acidification profile, probiotic in vitro gastrointestinal tolerance and viability in fermented milk with fruit flours. Int. Dairy J. 2015, 41, 1–6. [Google Scholar] [CrossRef]
  26. Kimoto-Nira, H.; Suzuki, C.; Sasaki, K.; Kobayashi, M.; Mizumachi, K. Survival of a Lactococcus lactis strain varies with its carbohydrate preference under in vitro conditions simulated gastrointestinal tract. Int. J. Food Microbiol. 2010, 143, 226–229. [Google Scholar] [CrossRef]
  27. Del Re, B.; Sgorbati, B.; Miglioli, M.; Palenzona, D. Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett. Appl. Microbiol. 2000, 31, 438–442. [Google Scholar] [CrossRef]
  28. Soundharrajan, I.; Kim, D.; Kuppusamy, P.; Muthusamy, K.; Lee, H.J.; Choi, K.C. Probiotic and Triticale Silage Fermentation Potential of Pediococcus pentosaceus and Lactobacillus brevis and Their Impacts on Pathogenic Bacteria. Microorganisms 2019, 7, 318. [Google Scholar] [CrossRef]
  29. Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 27th ed.; CLSI Supplement M100; Clinical and Laboratory Standards Institute: Wayne, PA, USA, 2017. [Google Scholar]
  30. Dowarah, R.; Verma, A.K.; Agarwal, N.; Singh, P.; Singh, B.R. Selection and characterization of probiotic lactic acid bacteria and its impact on growth, nutrient digestibility, health and antioxidant status in weaned piglets. PLoS ONE 2018, 13, e0192978. [Google Scholar] [CrossRef]
  31. Soleimani, N.; Kermanshahi, R.; Yakhchali, B.; Sattari, T. Antagonistic activity of probiotic lactobacilli against Staphylococcus aureus isolated from bovine mastitis. Afr. J. Microbiol. Res. 2010, 420, 2169–2173. [Google Scholar]
  32. Gomes, T.A.T.; Elias, W.P.; Scaletsky, I.C.A.; Guth, B.E.C.; Rodrigues, J.F.; Piazza, R.M.F.; Ferreira, L.C.S.; Martinez, M.B. Diarrheagenic Escherichia coli. Braz. J. Microbiol. 2016, 47, 3–30. [Google Scholar] [CrossRef]
  33. von Klitzing, E.; Ekmekciu, I.; Bereswill, S.; Heimesaat, M.M. Acute ileitis facilitates infection with multidrug resistant Pseudomonas aeruginosa in human microbiota-associated mice. Gut Pathog. 2017, 9, 4. [Google Scholar] [CrossRef] [PubMed]
  34. Strickertsson, J.A.B.; Desler, C.; Martin-Bertelsen, T.; Machado, A.M.D.; Wadstrøm, T.; Winther, O.; Rasmussen, L.J.; Friis-Hansen, L. Enterococcus faecalis Infection Causes Inflammation, Intracellular Oxphos-Independent ROS Production, and DNA Damage in Human Gastric Cancer Cells. PLoS ONE 2013, 8, e63147. [Google Scholar] [CrossRef] [PubMed]
  35. Klein, R.D.; Hultgren, S.J. Urinary tract infections: Microbial pathogenesis, host-pathogen interactions and new treatment strategies. Nat. Rev. Microbiol. 2020, 18, 211–226. [Google Scholar] [CrossRef]
  36. Weiner, L.M.; Webb, A.K.; Limbago, B.; Dudeck, M.A.; Patel, J.; Kallen, A.J.; Edwards, J.R.; Sievert, D.M. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011–2014. Infect. Control Hosp. Epidemiol. 2016, 37, 1288–1301. [Google Scholar] [CrossRef]
  37. Sharma, C.; Singh, B.P.; Thakur, N.; Gulati, S.; Gupta, S.; Mishra, S.K.; Panwar, H. Antibacterial effects of Lactobacillus isolates of curd and human milk origin against food-borne and human pathogens. 3 Biotech. 2017, 7, 31. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  38. Suissa, R.; Oved, R.; Jankelowitz, G.; Turjeman, S.; Koren, O.; Kolodkin-Gal, I. Molecular genetics for probiotic engineering: Dissecting lactic acid bacteria. Trends Microbiol. 2021, 30, 293–306. [Google Scholar] [CrossRef] [PubMed]
  39. Fuochi, V.; Petronio, G.P.; Lissandrello, E.; Furneri, P.M. Evaluation of resistance to low pH and bile salts of human Lactobacillus spp. isolates. Int. J. Immunopathol. Parmacol. 2015, 28, 426–433. [Google Scholar] [CrossRef]
  40. Shewale, R.N.; Sawale, P.; Khedkar, C.; Singh, A. Selection criteria for probiotics: A review. Int. J. Probiotics Prebiotics 2014, 9, 17–22. [Google Scholar]
  41. Wang, Y.; Li, A.; Jiang, X.; Zhang, H.; Mehmood, K.; Zhang, L.; Jiang, J.; Waqas, M.; Iqbal, M.; Li, J. Probiotic Potential of Leuconostoc pseudomesenteroides and Lactobacillus Strains Isolated From Yaks. Front. Microbiol. 2018, 9, 2987. [Google Scholar] [CrossRef]
  42. Huang, Y.-H.; Chen, Y.-H.; Chen, J.-H.; Hsu, P.-S.; Wu, T.-H.; Lin, C.-F.; Peng, C.-C.; Wu, M.-C. A potential probiotic Leuconostoc mesenteroides TBE-8 for honey bee. Sci. Rep. 2021, 11, 18466. [Google Scholar] [CrossRef]
  43. Begley, M.; Gahan, C.G.; Hill, C. The interaction between bacteria and bile. FEMS Microbiol. Rev. 2005, 29, 625–651. [Google Scholar] [CrossRef]
  44. Mourad, K.; Karam, N.E. Microbiological study of naturally fermented Algerian green olives: Isolation and identification of lactic acid bacteria and yeasts along with the effects of brine solutions obtained at the end of olive fermentation on Lactobacillus plantarum growth. Grasas Aceites 2006, 57, 292–300. [Google Scholar] [CrossRef]
  45. Buriti, F.C.; Castro, I.A.; Saad, S.M. Viability of Lactobacillus acidophilus in synbiotic guava mousses and its survival under in vitro simulated gastrointestinal conditions. Int. J. Food Microbiol. 2010, 137, 121–129. [Google Scholar] [CrossRef]
  46. Yadav, R.; Shukla, P. An overview of advanced technologies for selection of probiotics and their expediency: A review. Criti. Rev. Food Sci. Nut. 2017, 57, 3233–3242. [Google Scholar] [CrossRef]
  47. Yadav, V.; Varum, F.; Bravo, R.; Furrer, E.; Bojic, D.; Basit, A.W. Inflammatory bowel disease: Exploring gut pathophysiology for novel therapeutic targets. Transl. Res. J. Lab. Clin. Med. 2016, 176, 38–68. [Google Scholar] [CrossRef] [PubMed]
  48. Bermudez-Brito, M.; Plaza-Díaz, J.; Muñoz-Quezada, S.; Gómez-Llorente, C.; Gil, A. Probiotic Mechanisms of Action. Ann. Nutr. Metab. 2012, 61, 160–174. [Google Scholar] [CrossRef] [PubMed]
  49. Cortés-Zavaleta, O.; López-Malo, A.; Hernández-Mendoza, A.; García, H.S. Antifungal activity of lactobacilli and its relationship with 3-phenyllactic acid production. Int. J. Food Microbiol. 2014, 173, 30–35. [Google Scholar] [CrossRef] [PubMed]
  50. Inglin, R.C.; Stevens, M.J.; Meile, L.; Lacroix, C.; Meile, L. High-throughput screening assays for antibacterial and antifungal activities of Lactobacillus species. J. Microbiol. Methods 2015, 114, 26–29. [Google Scholar] [CrossRef] [PubMed]
  51. Chang, J.Y.; Chang, H.C. Growth inhibition of foodborne pathogens by kimchi prepared with bacteriocin-producing starter culture. J. Food Sci. 2011, 76, M72–M78. [Google Scholar] [CrossRef] [PubMed]
Microorganisms 11 00469 g001 550
Figure 1. Probiotic characteristics of L. citreum KCC-57 and L. citreum KCC-58. (A) Survival ability of KCC-57 and KCC-58 in simulated gastrointestinal juices, (B) hydrophobicity properties of KCC-57 and KCC-58 in different hydrocarbons, (C) auto-aggregation property of KCC-57 and KCC-58 in a time-based incubation. The data are represented as the mean ± STD of six replicates. Different alphabets within the figure indicate significant differences between experimental data at the 0.05 level.
Figure 1. Probiotic characteristics of L. citreum KCC-57 and L. citreum KCC-58. (A) Survival ability of KCC-57 and KCC-58 in simulated gastrointestinal juices, (B) hydrophobicity properties of KCC-57 and KCC-58 in different hydrocarbons, (C) auto-aggregation property of KCC-57 and KCC-58 in a time-based incubation. The data are represented as the mean ± STD of six replicates. Different alphabets within the figure indicate significant differences between experimental data at the 0.05 level.
Microorganisms 11 00469 g001
Microorganisms 11 00469 g002 550
Figure 2. Antibacterial activity of CFS of KCC-57 by dose- and time-dependent killing assay method. (A) CFS vs. P. aeruginosa, (B) CFS vs. S. aureus, (C) CFS vs. E. coli, (D) CFS vs. E. faecalis. The data are expressed as the mean ± STD (n = 3).
Figure 2. Antibacterial activity of CFS of KCC-57 by dose- and time-dependent killing assay method. (A) CFS vs. P. aeruginosa, (B) CFS vs. S. aureus, (C) CFS vs. E. coli, (D) CFS vs. E. faecalis. The data are expressed as the mean ± STD (n = 3).
Microorganisms 11 00469 g002
Microorganisms 11 00469 g003 550
Figure 3. Antibacterial activity of CFS of KCC-58 by dose- and time-dependent killing assays. (A) CFS vs. P. aeruginosa, (B) CFS vs. S. aureus, (C) CFS vs. E. coli, (D) CFS vs. E. faecalis. The data are expressed as the mean ± STD (n = 3).
Figure 3. Antibacterial activity of CFS of KCC-58 by dose- and time-dependent killing assays. (A) CFS vs. P. aeruginosa, (B) CFS vs. S. aureus, (C) CFS vs. E. coli, (D) CFS vs. E. faecalis. The data are expressed as the mean ± STD (n = 3).
Microorganisms 11 00469 g003
Table
Table 1. Morphophysiological features of identified isolates of L. citreum KCC-57 and L. citreum KCC-58.
Table 1. Morphophysiological features of identified isolates of L. citreum KCC-57 and L. citreum KCC-58.
Code StainMotileShapeCatalaseGrowth ConditionStrain Species
KCC-57PositiveNonCocciNegativeFacultative anaerobicLeuconostoccitreum
KCC-58PositiveNonCocciNegativeFacultative anaerobicLeuconostoccitreum
Table
Table 2. Antibacterial activity of CFS of KCC-57 and KCC-58 by well diffusion method.
Table 2. Antibacterial activity of CFS of KCC-57 and KCC-58 by well diffusion method.
CodeSpecies NameZone of Inhibition (mm)
E. coliS. aureusP. aeruginosaE. faecalis
KCC-57L. citreum34.3 ± 1.222.0 ± 2.917.5 ± 0.3518.5 ± 1.06
KCC-58L. citreum32.6 ± 2.427.3 ± 3.218.5 ± 0.3522.5 ± 1.77
CFS: Cell free supernatant.
Table
Table 3. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of CFS of KCC-57 and KCC-58.
Table 3. Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of CFS of KCC-57 and KCC-58.
PathogensKCC-57KCC-58
MIC (mg/mL)MBC (mg/mL)MIC (mg/mL)MBC (mg/mL)
E. coli12.52512.525
E. faecalis12.5-6.2512.5
P. aeruginosa12.52512.525
S. aureus25-12.525
Table
Table 4. Antibacterial activity of live L. citreum against various pathogens using co-culture method.
Table 4. Antibacterial activity of live L. citreum against various pathogens using co-culture method.
GroupsGrowth on MRA AgarGrowth on NA GroupsGrowth on MRA AgarGrowth on NAGroupsGrowth on NA
Bacterial growth (107 CFU/mL) after 12 h
KCC-57 alone5.92 ± 0.68 KCC-58 alone5.72 ± 0.42
KCC-57 ± SA2.52 ± 0.690.38 ± 0.12KCC-58 + SA4.32 ± 1.300.776 ± 0.07SA alone28.0 ± 0.56
KCC-57 ± PA5.10 ± 0.660.78 ± 0.02KCC-58 + PA4.56 ± 0.050.736 ± 0.03PA alone28.4 ± 1.98
KCC-57 ± EC5.80 ± 0.140.02 ± 0.02KCC-58EC2.60 ± 1.13 0.028 ± 0.02EC alone29.5 ± 2.80
KCC-57 ± EF3.40 ± 0.560.18 ± 0.02KCC-58 + EF3.60 ± 0.280.144 ± 0.01EF alone23.4 ± 0.07
Bacterial growth (107 CFU/mL) after 24 h
KCC-57 alone6.92 ± 0.19 KCC-58 alone7.72 ± 0.65
KCC-57 + SA1.16 ± 0.030.564 ± 0.10KCC-58 + SA2.46 ± 0.050.10 ± 0.01SA alone54.0 ± 6.29
KCC-57 + PA1.02 ± 0.010.288 ± 0.01KCC-58 + PA3.32 ± 0.070.23 ± 0.04PA alone47.3 ± 1.81
KCC-57 + EC3.80 ± 0.140.104 ± 0.01KCC-58 + EC2.70 ± 0.011.36 ± 0.07EC alone35.6 ± 2.26
KCC-57 + EF3.50 ± 0.350.288 ± 0.09KCC-58 + EF3.20 ± 0.420.14 ± 0.01EF alone38.7 ± 3.40
Bacterial growth (107 CFU/mL) after 36 h
KCC-57 alone6.66 ± 0.24 KCC-58 alone 6.49 ± 0.46
KCC-57 + SA2.21 ± 0.500.384 ± 0.12KCC-58 + SA1.59 ±0.520.676 ± 0.07SA alone48.8 ± 2.95
KCC-57 + PA3.34 ± 0.080.528 ± 0.34KCC-58 + PA1.64 ± 0.151.080 ± 0.09PA alone33.8 ± 2.07
KCC-57 + EC3.00 ± 0.420.116 ± 0.03KCC-58 + EC2.50 ± 0.210.064 ± 0.01EC alone37.7 ± 2.76
KCC-57 + EF2.30± 0.210.120 ± 0.00KCC-58 + EF2.10 ± 0.490.120 ± 0.01EF alone38.5 ± 5.03
SA-Staphylococcus aureus; PA-Pseudomonas aeruginosa; EC-Escherichia coli, and EF-Enterococcus faecalis. Co-culture: both LAB and pathogen were grown in modified media (MRS: NA 1:1); monoculture: both LAB and pathogen were grown in modified media; both cultures were incubated at 37 °C for 48 h. LAB and pathogen colonies were monitored using MRS and NA plates, respectively. The data were then compared with monoculture. Data are presented as mean ± standard deviation (n = 3).
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Muthusamy, K.; Han, H.-S.; Soundharrajan, I.; Jung, J.-S.; Valan Arasu, M.; Choi, K.-C. A Novel Strain of Probiotic Leuconostoc citreum Inhibits Infection-Causing Bacterial Pathogens. Microorganisms 2023, 11, 469. https://doi.org/10.3390/microorganisms11020469

AMA Style

Muthusamy K, Han H-S, Soundharrajan I, Jung J-S, Valan Arasu M, Choi K-C. A Novel Strain of Probiotic Leuconostoc citreum Inhibits Infection-Causing Bacterial Pathogens. Microorganisms. 2023; 11(2):469. https://doi.org/10.3390/microorganisms11020469

Chicago/Turabian Style

Muthusamy, Karnan, Hyo-Shim Han, Ilavenil Soundharrajan, Jeong-Sung Jung, Mariadhas Valan Arasu, and Ki-Choon Choi. 2023. "A Novel Strain of Probiotic Leuconostoc citreum Inhibits Infection-Causing Bacterial Pathogens" Microorganisms 11, no. 2: 469. https://doi.org/10.3390/microorganisms11020469

APA Style

Muthusamy, K., Han, H.-S., Soundharrajan, I., Jung, J.-S., Valan Arasu, M., & Choi, K.-C. (2023). A Novel Strain of Probiotic Leuconostoc citreum Inhibits Infection-Causing Bacterial Pathogens. Microorganisms, 11(2), 469. https://doi.org/10.3390/microorganisms11020469

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop